Proteomic Analysis of Secretomes of Oncolytic Herpes Simplex Virus-Infected Squamous Cell Carcinoma Cells. 2018

Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry, Suita, Osaka 565-0871, Japan. dt3034ts@yahoo.co.jp.

Oncolytic herpes simplex virus type 1 (HSV-1) strain RH2 induced immunogenic cell death (ICD) with the release and surface exposure of damage-associated molecular patterns (DAMPs) in squamous cell carcinoma (SCC) SCCVII cells. The supernatants of RH2-infected SCCVII cells also exhibited antitumor ability by intratumoral administration in SCCVII tumor-bearing mice. The supernatants of RH2-infected cells and mock-infected cells were concentrated to produce Med24 and MedC for proteomic analyses. In Med24, the up- and down-regulated proteins were observed. Proteins including filamin, tubulin, t-complex protein 1 (TCP-1), and heat shock proteins (HSPs), were up-regulated, while extracellular matrix (ECM) proteins were markedly down-regulated. Viral proteins were detected in Med 24. These results indicate that HSV-1 RH2 infection increases the release of danger signal proteins and viral gene products, but decreases the release of ECM components. These changes may alter the tumor microenvironment (TME) and contribute to enhancement of anti-tumor immunity against SCC.

UI MeSH Term Description Entries

Related Publications

Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
October 2015, Viruses,
Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
April 2016, Cancer gene therapy,
Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
January 2008, Anticancer research,
Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
January 2022, BMC infectious diseases,
Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
June 2011, Virology journal,
Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
September 2013, Cancer gene therapy,
Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
September 2017, Cancer gene therapy,
Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
July 2001, Journal of the American College of Surgeons,
Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
March 2009, Cancer gene therapy,
Shinya Tada, and Masakazu Hamada, and Yoshiaki Yura
January 2016, Pathology,
Copied contents to your clipboard!